Generali Investments Management Co LLC Acquires New Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Generali Investments Management Co LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, Holdings Channel reports. The fund acquired 4,703 shares of the company’s stock, valued at approximately $368,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. OVERSEA CHINESE BANKING Corp Ltd acquired a new position in GE HealthCare Technologies during the 4th quarter valued at approximately $362,000. Xponance Inc. boosted its position in GE HealthCare Technologies by 8.4% during the 4th quarter. Xponance Inc. now owns 68,810 shares of the company’s stock valued at $5,380,000 after purchasing an additional 5,346 shares during the period. Intech Investment Management LLC boosted its position in GE HealthCare Technologies by 1,429.4% during the 4th quarter. Intech Investment Management LLC now owns 312,080 shares of the company’s stock valued at $24,398,000 after purchasing an additional 291,675 shares during the period. Horizon Investments LLC boosted its position in GE HealthCare Technologies by 3.8% during the 4th quarter. Horizon Investments LLC now owns 5,983 shares of the company’s stock valued at $468,000 after purchasing an additional 221 shares during the period. Finally, Advisors Asset Management Inc. boosted its position in GE HealthCare Technologies by 7.1% during the 4th quarter. Advisors Asset Management Inc. now owns 104,343 shares of the company’s stock valued at $8,158,000 after purchasing an additional 6,913 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.4 %

GEHC opened at $82.14 on Wednesday. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock’s fifty day moving average is $87.25 and its 200-day moving average is $86.10. The company has a market capitalization of $37.56 billion, a PE ratio of 18.97, a P/E/G ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have weighed in on GEHC shares. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average target price of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.